Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers

Clinical and Experimental Immunology

Volumn 119, Issue 2, 2000, Pages 259-263

  Araki, K ^a,c   Harada, K ^a   Nakamoto, K ^a   Shiroma, M ^a   Miyakuni, T ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Department of Surgery   (Japan)

^c School of Health Science   (Japan)

Author keywords

Adult T cell leukaemia; HTLV 1; HTLV 1 carrier; Mitogenic response; SIL 2R

Indexed keywords

INTERLEUKIN 2;

ARTICLE; BLOOD DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE STATUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERUM; T CELL LEUKEMIA; VIRUS CARRIER;

ADULT; AUTOIMMUNE DISEASES; CARRIER STATE; CELL-FREE SYSTEM; CELLS, CULTURED; HTLV-I INFECTIONS; HUMANS; K562 CELLS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LEUKOCYTES, MONONUCLEAR; RECEPTORS, INTERLEUKIN-2; SOLUBILITY;

EID: 0033979306     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01136.x     Document Type: Article

References (20)

1. Uchiyama T, Yodoi J, Sagawa K et al. Adult T cell leukemia: Clinical and hematological features of 16 cases. Blood 1977; 50:481-91.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterisation of a retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1980; 77:7415-9.
3. Osame M, Usuku K, Izumo S et al. HTLV-I-associated myelopathy, a new clinical entity. Lancet 1986; i:1031-2.
4. Mochizuki M, Watanabe T, Yamaguchi K et al. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I. Jap J Cancer Res 1992; 83:236-9.
5. x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J 1986; 5:561-5.
6. Maeda M, Shimizu A, IKuta K et al. Origin of human T-lymphotropic virus I-positive T-cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med 1985; 162:2169-74.
7. Uchiyama T, Hori T, Tsudo M et al. Interleukin -2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 1985; 76:446-53.
8. Marcon L, Rubin AL, Kurman CC et al. Elevated serum levels of soluble Tac peptide in adult T-cell leukemia: Correlation with clinical status during chemotherapy. Ann Intern Med 1988; 109: 274-9.
9. Mori N, Murakami S, Oda S et al. An HTLV-I carrier who developed CD4+ T-cell expressed the 1L-2R receptor β chain alone without expressing the α chain. Br J Haemat 1993; 85:185-7.
10. Roesseer E, Grant A, Ju G et al. Cooperative interactions between the interleukin 2 receptor α and β chains alter the interleukin 2-binding affinity of the receptor subunits. Proc Natl Acad Sci USA 1994; 91:3344-7.
11. Sugawara K, Takashima T, Asao H et al. The IL-2/IL-2 receptor system. Involvement of a novel receptor subunit, γ chain, in growth signal transduction. Tohoku J Exp Med 1992; 168:231-7.
12. Nakarai T, Robertson MJ, Streuli M et al. Interleukin 2 receptor γ chain expression on resting and activated lymphoid cells. J Exp Med 1994; 180:241-51.
13. Osawa H, Josimovic-Alasevic O, Diamantstein T. Interleukin 2 receptors are released by cells in vitro and in vivo I. Detection of soluble IL-2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay. Eur J Immunol 1986; 16:467-9.
14. Rubin LA, Kurman CC, Frits ME et al. Soluble interleukin 2 receptor is released from activated human lymphoid cells in vitro. J Immunol 1985; 135:3172-7.
15. Shimoyama M, Members Of the Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma. A report from the lymphoma study group (1984-1987). Br J Hematol 1991; 79:428-37.
16. Yasuda N, Lai PK, Ip SH et al. Soluble interleukin 2 receptors in sera of japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71:1021-6.
17. Shimoyama M, Ota K, Kikuchi M et al. (1981-1983). Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol 1988; 6:1088-97.
18. Kamihira S, Atogami S, Shoda H et al. Significance of soluble interleukin 2 receptor levels for evaluation of the progression of adult t-cell leukemia. Cancer 1994; 73:2753-8.
19. Wagner DK, Kiwanuka J, Edward BK et al. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: Correlation with survival. J Clin Oncol 1987; 5:1262-74.
20. Katoh T, Harada T, Morikawa S et al. IL-2- and IL- 2r-independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients. Int J Cancer 1986; 38:265-74.